An Antioxidant Sesquiterpene Inhibits Osteoclastogenesis Via Blocking IPMK/TRAF6 and Counteracts OVX-Induced Osteoporosis in Mice
Open Access
- 1 December 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 36 (9) , 1850-1865
Abstract
Excessive bone resorption induced by increased osteoclast activity in postmenopausal women often causes osteoporosis. Although the pharmacological treatment of osteoporosis has been extensively developed, a safer and more effective treatment is still needed. Here, we found that curcumenol (CUL), an anti‐oxidant sesquiterpene isolated from Curcuma zedoaria, impaired receptor activator of nuclear factor‐κB (NF‐κB) ligand (RANKL)‐induced osteoclastogenesis in vitro, whereas the osteoblastogenesis of MC3T3‐E1 cells was not affected. We further demonstrated that CUL treatment during RANKL‐induced osteoclastogenesis promotes proteasomal degradation of TRAF6 by increasing its K48‐linked polyubiquitination, leading to suppression of mitogen‐activated protein kinases (MAPKs) and NF‐κB pathways, and the production of reactive oxygen species (ROS). We also showed that inositol polyphosphate multikinase (IPMK) binds with TRAF6 to reduce its K48‐linked polyubiquitination under RANKL stimulation. Concurrently, IPMK deficiency inhibits osteoclast differentiation. The binding between IPMK and TRAF6 blocked by CUL treatment was found in our study. Finally, we confirmed that CUL treatment prevented ovariectomy (OVX)‐induced bone loss in mice. In summary, our study demonstrates that CUL could impair the stability of TRAF6 enhanced by IPMK and suppress excessive osteoclast activity in estrogen‐deficient mice to treat osteoporosis.Keywords
Funding Information
- National Nature Science Fund of China (81972089, 82002334)
- Natural Science Fund of Zhejiang Province (Q20H060042)
This publication has 53 references indexed in Scilit:
- WW Domain Containing E3 Ubiquitin Protein Ligase 1 (WWP1) Negatively Regulates TLR4-Mediated TNF-α and IL-6 Production by Proteasomal Degradation of TNF Receptor Associated Factor 6 (TRAF6)PLOS ONE, 2013
- The association between serious upper gastrointestinal bleeding and incident bisphosphonate use: a population-based nested cohort studyBMC Geriatrics, 2013
- Disorders of Bone RemodelingAnnual Review of Pathology: Mechanisms of Disease, 2011
- Amino Acid Signaling to mTOR Mediated by Inositol Polyphosphate MultikinaseCell Metabolism, 2011
- TRAF6 Autoubiquitination-Independent Activation of the NFκB and MAPK Pathways in Response to IL-1 and RANKLPLOS ONE, 2008
- The RING Domain and First Zinc Finger of TRAF6 Coordinate Signaling by Interleukin-1, Lipopolysaccharide, and RANKLJournal of Biological Chemistry, 2008
- The AP-1 site is essential for the promoter activity of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme: Possible involvement of the ERK1/2-JunB pathwayBiochemical and Biophysical Research Communications, 2008
- Negative regulation of Toll-like receptor-mediated immune responsesNature Reviews Immunology, 2005
- Osteoclast differentiation and activationNature, 2003
- Receptor Activator of NF-κB Ligand (RANKL) Activates TAK1 Mitogen-Activated Protein Kinase Kinase Kinase through a Signaling Complex Containing RANK, TAB2, and TRAF6Molecular and Cellular Biology, 2002